Cite
MLA Citation
Dean A Fennell et al.. “Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.” Lancet oncology, vol. 22, no. 11, 2021, pp. 1530–1540. http://access.bl.uk/ark:/81055/vdc_100145644182.0x00000d